EW Healthcare Partners related stories
All articles and analysis
NY-based Invidia Capital Management adds third partner in two monthsUntil July, the healthcare-focused firm’s sole partner was its founder, the former global head of healthcare private investing at Goldman Sachs
EW Healthcare Partners acquires MajorelleEW Healthcare Partners has acquired a majority stake in Paris-based Majorelle, a specialty pharma company focused on prescription and OTC products in women’s health and urology.
Grooming tech to keep hospitals cleanA bevy of start-ups in recent years have emerged to help disinfect all aspects of hospitals, from handwashing to patient rooms to healthcare devices. This seemed like a novel idea before covid-19, but it’s essential now.
Cognate Bioservices takes in Series B, also buys Cobra BiologicsCognate Bioservices, a contract development and manufacturing organization specializing in cell and cell-mediated gene therapy products, has closed its Series B funding round.
Dental tech company rakes in $85 mlnSonendo, a dental tech company, has secured $85 million in funding.
- Cognate acquires Cobra Biologics
Cognate BioServices has acquired UK and Sweden-based Cobra Biologics, an advanced therapy CDMO that specializes in providing manufacturing services for the plasmid DNA and viral vector. No financial terms were disclosed. Cognate's backers include EW Healthcare Partners.
EW Healthcare Partners raises $746.33mThe Houston-based growth equity firm closed its latest healthcare technology fund.
- EW Healthcare invests in Cognate BioServices
EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren’t announced. Cognate BioServices is a contract development and manufacturing organization.
- EW Healthcare Partners racks up $745 mln for fund
EW Healthcare Partners has raised $745 million for its second growth equity fund, beating its $650 million target. Fund2a targets healthcare companies in the pharmaceutical, medical device, diagnostics and technology-enabled services sectors in the U.S. and in Europe.